Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Among these potential key players, Roche continues to stand out with multiple obesity candidates within its pipeline, all in phase II trials (as of November 2025), and it is expected to enter the market in 2029 or later
Mainly because I am not super consistent
It is commonly used in surgical procedures, dental procedures, and for pain management in various medical settings
Physicochemical Properties The isoelectric point (pI) of AOD-9604 is approximately 8.0, reflecting its net positive charge at physiological pH
US$ 20.64
US$ 25.98
US$ 25.68
US$ 24.66
US$ 27.11
US$ 23.68
